Overview
Heart-lung transplant failure and rejection involve dysfunction of both the heart and lung grafts post-transplantation, necessitating prompt diagnosis and management to improve outcomes 12.Diagnosis
Assess graft function through gas exchange, pulmonary function tests, and serial imaging (e.g., chest X-rays) 1.
Monitor biochemical markers such as LDH and CPK levels to detect early signs of graft injury 2.
Evaluate hemodynamic parameters including pressures in the left ventricle, aorta, and coronary arteries 2.Management
Utilize optimized preservation techniques, such as cold crystalloid cardioplegic arrest and colloid pulmonary artery flush, to minimize ischemic time 1.
Consider hypothermic machine perfusion with solutions like TP-V, potentially enhanced with oxygen free radical scavengers (e.g., Allopurinol, Catalase) to improve graft viability 2.
Employ immunosuppressive therapy (specific drug classes and doses not detailed in provided abstracts) to prevent rejection 1.Special Populations
No specific details provided regarding pregnancy, pediatrics, elderly, or comorbidities in managing heart-lung transplant failure and rejection 12.Key Recommendations
Minimize ischemic time during organ procurement to optimize early graft function (Evidence: Moderate) 1.
Implement advanced preservation methods, including the use of oxygen free radical scavengers, to enhance graft viability post-preservation (Evidence: Moderate) 2.
Initiate tailored immunosuppressive therapy to prevent rejection, though specific dosing and classes are not detailed in current evidence (Evidence: Expert opinion) 1.References
1 McGoldrick JP, Scott JP, Smyth R, Higenbottam T, Wallwork J. Early graft function after heart-lung transplantation. The Journal of heart transplantation 1990. link
2 Hajjar G, Toledo-Pereyra LH, Mackenzie GH. Effect of 24-hour preservation with oxygen free radical scavengers on isolated-perfused canine heart-lungs. Puerto Rico health sciences journal 1986. link